Keyphrases
Escherichia Coli
100%
Antibiotic Use
100%
Teaching Hospital
100%
Pakistan
100%
Positive Culture
100%
Methicillin-resistant Staphylococcus Aureus
100%
Antibiotic De-escalation
100%
Amikacin
66%
Cefoperazone-sulbactam
50%
Antimicrobial Therapy
33%
Colistin
33%
Linezolid
33%
Empirical Therapy
33%
Broad-spectrum Antibiotics
33%
Tigecycline
33%
Culture Sensitivity Reports
33%
Fosfomycin
33%
Antimicrobial Stewardship Program
16%
Ceftriaxone
16%
Antibiotics
16%
Metronidazole
16%
Ciprofloxacin
16%
Local Antimicrobials
16%
Antimicrobial Susceptibility Pattern
16%
Definitive Treatment
16%
Resistance Emergence
16%
Meropenem
16%
Vancomycin
16%
Clindamycin
16%
Infected Patients
16%
Chloramphenicol
16%
Susceptibility Testing
16%
Oxacillin
16%
Prospective Observational Study
16%
Sensitivity Test
16%
Cefoxitin
16%
Polymyxin B
16%
Piperacillin-tazobactam
16%
Demographic Data
16%
Spread of Resistance
16%
Antibiotic Therapy
16%
Local Hospital
16%
Microbes
16%
Culture Sensitivity
16%
Isolated Microorganisms
16%
Medical Files
16%
Pathogen Detection
16%
Infected Area
16%
Pharmacology, Toxicology and Pharmaceutical Science
Escherichia coli
100%
Methicillin Susceptible Staphylococcus Aureus
100%
Amikacin
66%
Antibiotics
50%
Antiinfective Agent
50%
Cefoperazone Plus Sulbactam
50%
Linezolid
33%
Colistimethate
33%
Tigecycline
33%
Fosfomycin
33%
Microorganism
33%
Ceftriaxone
16%
Infectious Agent
16%
Clindamycin
16%
Vancomycin
16%
Chloramphenicol
16%
Meropenem
16%
Ciprofloxacin
16%
Observational Study
16%
Metronidazole
16%
Antimicrobial Therapy
16%
Pus
16%
Cefoxitin
16%
Polymyxin B
16%
Piperacillin Plus Tazobactam
16%
Antibiotic Therapy
16%
Oxacillin
16%